https://doi.org/10.1002/ejhf.424. PMID: 26548803.

2. Sato H., Taiteishi H., Uchida T. et al. Takotsubo-type cardiomyopathy due to multivessel spasm. In: Kodama K., Haze K., Hon M. Clinical aspect of myocardial injury: From ischemia to heart failure. Tokyo: Kagakuhyouronsha, 1990; 56–64.

3. Templin C., Napp L.C., Ghadri J.R. Takotsubo syndrome: Underdiagnosed, underestimated, but understood? J Am Coll Cardiol. 2016; 67(16): 1937–40.

https://doi.org/10.1016/j.jacc.2016.03.006. PMID: 27102509.

4. Prasad A., Dangas G., Srinivasan M. et al. Incidence and angiographic characteristics of patients with apical ballooning syndrome (takotsubo/stress cardiomyopathy) in the HORIZONS-AMI trial: An analysis from a multicenter, international study of ST-elevation myocardial infarction. Catheter Cardiovasc Interv. 2014; 83(3): 343–48.

https://doi.org/10.1002/ccd.23441. PMID: 22121008.

5. Bybee K.A., Prasad A., Barsness G.W. et al. Clinical characteristics and thrombolysis in myocardial infarction frame counts in women with transient left ventricular apical ballooning syndrome. Am J Cardiol. 2004; 94(3): 343–46.

https://doi.org/10.1016/j.amjcard.2004.04.030. PMID: 15276100.

6. Redfors B., Vedad R., Angeras O. et al. Mortality in takotsubo syndrome is similar to mortality in myocardial infarction – A report from the SWEDEHEART registry. Int J Cardiol. 2015; 185: 282–89.

https://doi.org/10.1016/j.ijcard.2015.03.162. PMID: 25818540.

7. Deshmukh A., Kumar G., Pant S. et al. Prevalence of takotsubo cardiomyopathy in the United States. Am Heart J. 2012; 164(1): 66–71.e1.

https://doi.org/10.1016/j.ahj.2012.03.020. PMID: 22795284.

8. Templin C., Ghadri J.R., Diekmann J. et al. Clinical features and outcomes of takotsubo (stress) cardiomyopathy. N Engl J Med. 2015; 373(10): 929–38.

https://doi.org/10.1056/NEJMoa1406761. PMID: 26332547.

9. Ghadri J.R., Wittstein I.S., Prasad A. et al. International Expert Consensus Document on takotsubo syndrome (part I): Clinical characteristics, diagnostic criteria, and pathophysiology. Eur Heart J. 2018; 39(22): 2032–46.

https://doi.org/10.1093/eurheartj/ehy076. PMID: 29850871. PMCID: PMC5991216.

10. Ueyama T., Kasamatsu K., Hano T. et al. Catecholamines and estrogen are involved in the pathogenesis of emotional stress-induced acute heart attack. Ann NY Acad Sci. 2008; 1148: 479–85.

https://doi.org/10.1196/annals.1410.079. PMID: 19120144.

11. Komesaroff P.A., Esler M.D., Sudhir K. Estrogen supplementation attenuates glucocorticoid and catecholamine responses to mental stress in perimenopausal women. J Clin Endocrinol Metab. 1999; 84(2): 606–10.

https://doi.org/10.1210/jcem.84.2.5447. PMID: 10022424.

12. Vriz O., Minisini R., Citro R. et al. Analysis of beta1 and beta2-adrenergic receptors polymorphism in patients with apical ballooning cardiomyopathy. Acta Cardiol. 2011; 66(6): 787–90.

https://doi.org/10.1080/ac.66.6.2136964. PMID: 22299391.

13. Zaroff J.G., Pawlikowska L., Miss J.C. et al. Adrenoceptor polymorphisms and the risk of cardiac injury and dysfunction after subarachnoid hemorrhage. Stroke. 2006; 37(7): 1680–85.

https://doi.org/10.1161/01.STR.0000226461.52423.dd. PMID: 16728691. PMCID: PMC4654957.

14. Sharkey S.W., Maron B.J., Nelson P. et al. Adrenergic receptor polymorphisms in patients with stress (tako-tsubo) cardiomyopathy. J Cardiol. 2009; 53(1): 53–57.

https://doi.org/10.1016/j.jjcc.2008.08.006. PMID: 19167638.

15. Eitel I., Moeller C., Munz M. et al. Genome-wide association study in takotsubo syndrome – Preliminary results and future directions. Int J Cardiol. 2017; 236: 335–39.

https://doi.org/10.1016/j.ijcard.2017.01.093. PMID: 28108127.

16. Delmas C., Lairez O., Mulin E. et al. Anxiodepressive disorders and chronic psychological stress are associated with tako-tsubo cardiomyopathy – New physiopathological hypothesis. Circ J. 2013; 77(1): 175–80.

https://doi.org/10.1253/circj.cj-12-0759. PMID: 22987076.

17. Болдуева С.А., Евдокимов Д.С. Кардиомиопатия такоцубо. Обзор данных литературы: понятие, эпидемиология, патогенез. Часть I. Российский кардиологический журнал. 2022; 27(S3): 108–119. (Boldueva S.A., Evdokimov D.S. Takotsubo cardiomyopathy. Literature review: concept, epidemiology, pathogenesis. Part I. Rossiyskiy kardiologicheskiy zhurnal =

Russian Journal of Cardiology. 2022; 27(S3): 108–119 (In Russ.)).

https://doi.org/10.15829/1560-4071-2022-4993. EDN: BQQYSD.

18. Sharkey S.W., Windenburg D.C., Lesser J.R. et al. Natural history and expansive clinical profile of stress (tako-tsubo) cardiomyopathy. J Am Coll Cardiol. 2010; 55(4): 333–41.

https://doi.org/10.1016/j.jacc.2009.08.057. PMID: 20117439.

19. Akashi Y.J., Nef H.M., Lyon A.R. Epidemiology and pathophysiology of takotsubo syndrome. Nat Rev Cardiol. 2015; 12(7): 387–97.

https://doi.org/10.1038/nrcardio.2015.39. PMID: 25855605.

20. Суспицына И.Н., Сукманова И.А. Синдром такоцубо. Клинико-патогенетические аспекты. Основы диагностики и лечения. Кардиология. 2020; 60(2): 96–103. (Suspitsyna I.N., Sukmanova I.A. Takotsubo syndrome. Clinical and pathogenetic aspects. Basics of diagnosis and treatment. Kardiologiya = Cardiology. 2020; 60(2): 96–103 (In Russ.)).

https://doi.org/10.18087/cardio.2020.2.n521. EDN: FTHXVU.

21. Scally C., Abbas H., Ahearn T. et al. Myocardial and systemic inflammation in acute stress-induced (takotsubo) cardiomyopathy. Circulation. 2019; 139(13): 1581–92.

https://doi.org/10.1161/circulationaha.118.037975. PMID: 30586731. PMCID: PMC6438459.

22. Neil C., Nguyen T.H., Kucia A. et al. Slowly resolving global myocardial inflammation/oedema in tako-tsubo cardiomyopathy: Evidence from T2-weighted cardiac MRI. Heart. 2012; 98(17): 1278–84.

https://doi.org/10.1136/heartjnl-2011-301481. PMID: 22791656.

23. Wilson H.M., Cheyne L., Brown P.A.J. et al. Characterization of the myocardial inflammatory response in acute stress-induced (takotsubo) cardiomyopathy. JACC Basic Transl Sci. 2018; 3(6): 766–78.

https://doi.org/10.1016/j.jacbts.2018.08.006. PMID: 30623136. PMCID: PMC6314973.

24. Salamanca J., Alfonso F. Takotsubo syndrome: Unravelling the enigma of the broken heart syndrome? A narrative review. Cardiovasc Diagn Ther. 2023; 13(6): 1080–103.

https://doi.org/10.21037/cdt-23-283. PMID: 38162098. PMCID: PMC10753233.

25. Arbelo E., Protonotarios A., Gimeno J.R. et al.; ESC Scientific Document Group. 2023 ESC Guidelines for the management of cardiomyopathies. Eur Heart J. 2023; 44(37): 3503–626.

https://doi.org/10.1093/eurheartj/ehad194. PMID: 37622657.

26. Яшин С.С., Киреева А.О., Сухачев П.А. Стресс-индуцированная кардиомиопатия (синдром такоцубо). Инновационная медицина Кубани. 2023; 8(1): 111–115. (Yashin S.S., Kireeva A.O., Sukhachev P.A. Stress cardiomyopathy (takotsubo cardiomyopathy). Innovatsionnaya meditsina Kubani = Innovative Medicine of Kuban. 2023; 8(1): 111–115 (In Russ.)).

https://doi.org/10.35401/2541-9897-2023-26-1-111-115. EDN: SCJNJL.

27. Aizawa K., Suzuki T. Takotsubo cardiomyopathy: Japanese perspective. Heart Fail Clin. 2013; 9(2): 243–47, x.

https://doi.org/10.1016/j.hfc.2012.12.001. PMID: 23562125.

28. Kagiyama N., Okura H., Kume T. et al. Isolated right ventricular takotsubo cardiomyopathy. Eur Heart J Cardiovasc Imaging. 2015; 16(3): 285.

https://doi.org/10.1093/ehjci/jeu207. PMID: 25352662.

29. Ghadri J.R., Cammann V.L., Jurisic S. et al.; InterTAK co-investigators. A novel clinical score (InterTAK Diagnostic Score) to differentiate takotsubo syndrome from acute coronary syndrome: Results from the International Takotsubo Registry. Eur J Heart Fail. 2017; 19(8): 1036–42.

https://doi.org/10.1002/ejhf.683. PMID: 27928880.

30. Nunez G., Andres M., Almendro Delia M. et al.; RETAKO investigators. Characterization of tako-tsubo cardiomyopathy in Spain: Results from the RETAKO National Registry. Rev Esp Cardiol (Engl Ed). 2015; 68(6): 505–12.

https://doi.org/10.1016/j.rec.2014.07.026. PMID: 25544669.

31. Болдуева С.А., Евдокимов Д.С. Кардиомиопатия такоцубо. Обзор данных литературы: клиническая картина, алгоритм диагностики, лечение, прогноз. Часть II. Российский кардиологический журнал. 2022; 27(S3): 120–128. (Boldueva S.A., Evdokimov D.S. Takotsubo cardiomyopathy. Literature review: clinical performance, diagnostic algorithm, treatment, prognosis. Part II. Rossiyskiy kardiologicheskiy zhurnal = Russian Journal of Cardiology. 2022; 27(S3): 120–128 (In Russ.)).

https://doi.org/10.15829/1560-4071-2022-4994. EDN: BVVIKY.

32. Внутренняя медицина, основанная на доказательствах. 2018. Под ред. Мартынова А.И., Кокорина В.А. Практическая медицина (Польша). 2018; 1680 с. (Evidence-based internal medicine. 2018. Ed. By Martynov A.I., Kokorin V.A. Practical Medicine (Poland). 2018; 1680 pp. (In Russ.)). ISBN: 978-83-7430-566-2.

33. Ghadri J.R., Wittstein I.S., Prasad A. et al. International Expert Consensus Document on takotsubo syndrome (part II): Diagnostic workup, outcome, and management. Eur Heart J. 2018; 39(22): 2047–62.

https://doi.org/10.1093/eurheartj/ehy077. PMID: 29850820. PMCID: PMC5991205.

34. Tarantino N., Santoro F., Guastafierro F. et al. “Lambda-wave” ST-elevation is associated with severe prognosis in stress (takotsubo) cardiomyopathy. Ann Noninvasive Electrocardiol. 2018; 23(6): e12581.

https://doi.org/10.1111/anec.12581. PMID: 29984535. PMCID: PMC6931687.

35. Frangieh A.H., Obeid S., Ghadri J.R. et al.; InterTAK Collaborators. ECG Criteria to differentiate between takotsubo (stress) cardiomyopathy and myocardial infarction. J Am Heart Assoc. 2016; 5(6): e003418.

https://doi.org/10.1161/JAHA.116.003418. PMID: 27412903. PMCID: PMC4937281.

36. Samul-Jastrzębska J., Roik M., Wretowski D. et al. Evaluation of the InterTAK Diagnostic Score in differentiating takotsubo syndrome from acute coronary syndrome. A single center experience. Cardiol J. 2021; 28(3): 416–22.

https://doi.org/10.5603/CJ.a2019.0086. PMID: 31489610. PMCID: PMC8169192.

37. Athanasiadis A., Schneider B., Sechtem U. Role of cardiovascular magnetic resonance in takotsubo cardiomyopathy. Heart Fail Clin. 2013; 9(2): 167–76, viii.

https://doi.org/10.1016/j.hfc.2012.12.011. PMID: 23562117.

38. Templin C., Ghadri J.R., Napp L.C. Takotsubo (stress) cardiomyopathy. N Engl J Med. 2015; 373(27): 2689–91.

https://doi.org/10.1056/NEJMc1512595. PMID: 26716925.

39. Machanahalli Balakrishna A., Ismayl M., Thandra A. et al. Diagnostic value of cardiac magnetic resonance imaging and intracoronary optical coherence tomography in patients with a working diagnosis of myocardial infarction with non-obstructive coronary arteries – A systematic review and meta-analysis. Curr Probl Cardiol. 2023; 48(6): 101126.

https://doi.org/10.1016/j.cpcardiol.2022.101126. PMID: 35120967.

40. Rawish E., Stiermaier T., Santoro F. et al. Current knowledge and future challenges in takotsubo syndrome: Part 1 – pathophysiology and diagnosis. J Clin Med. 2021; 10(3): 479.

https://doi.org/10.3390/jcm10030479. PMID: 33525539. PMCID: PMC7865728.

41. Couch L.S., Garrard J.W., Henry J.A. et al. Comparison of troponin and natriuretic peptides in takotsubo syndrome and acute coronary syndrome: A meta-analysis. Open Heart. 2024; 11(1): e002607.

https://doi.org/10.1136/openhrt-2024-002607. PMID: 38508657. PMCID: PMC10952941.

42. Nguyen T.H., Neil C.J., Sverdlov A.L. et al. N-terminal pro-brain natriuretic protein levels in takotsubo cardiomyopathy. Am J Cardiol. 2011; 108(9): 1316–21.

https://doi.org/10.1016/j.amjcard.2011.06.047. PMID: 21871590.

43. Santoro F., Mallardi A., Leopizzi A. et al. Current knowledge and future challenges in takotsubo syndrome: Part 2 – treatment and prognosis. J Clin Med. 2021; 10(3): 468.

https://doi.org/10.3390/jcm10030468. PMID: 33530545. PMCID: PMC7866173.

44. Girardis M., Bettex D., Bojan M. et al. Levosimendan in intensive care and emergency medicine: literature update and expert recommendations for optimal efficacy and safety. J Anesth Analg Crit Care. 2022; 2(1): 4.

https://doi.org/10.1186/s44158-021-00030-7. PMID: 37386589. PMCID: PMC8785009.

45. Raposeiras-Roubín S., Núñez-Gil I.J., Jamhour K. et al. RETAKO Investigators. Long-term prognostic impact of beta-blockers in patients with takotsubo syndrome: Results from the RETAKO Registry. Rev Port Cardiol. 2023; 42(3): 237–46.

https://doi.org/10.1016/j.repc.2022.02.010. PMID: 36634757.

46. Petursson P., Ostarijas E., Redfors B. et al. Effects of pharmacological interventions on mortality in patients with takotsubo syndrome: A report from the SWEDEHEART registry. ESC Heart Fail. 2024.

https://doi.org/10.1002/ehf2.14713. PMID: 38454651. Online ahead of print.

47. Almendro-Delia M., Nunez-Gil I.J., Lobo M. et al.; RETAKO Investigators. Short- and long-term prognostic relevance of cardiogenic shock in takotsubo syndrome: Results from the RETAKO Registry. JACC Heart Fail. 2018; 6(11): 928–36.

https://doi.org/10.1016/j.jchf.2018.05.015. PMID: 30316938.

48. Gili S., Cammann V.L., Schlossbauer S.A. et al. Cardiac arrest in takotsubo syndrome: Results from the InterTAK Registry. Eur Heart J. 2019; 40(26): 2142–51.

https://doi.org/10.1093/eurheartj/ ehz170. PMID: 31098611. PMCID: PMC6612368.

49. Kosmas N., Manolis A.S., Dagres N., Iliodromitis E.K. Myocardial infarction or acute coronary syndrome with non-obstructive coronary arteries and sudden cardiac death: A missing connection. Europace. 2020; 22(9): 1303–10.

https://doi.org/10.1093/europace/euaa156. PMID: 32894280. PMCID: PMC7478321.

50. Schneider B., Athanasiadis A., Schwab J. et al. Complications in the clinical course of tako-tsubo cardiomyopathy. Int J Cardiol. 2014; 176(1): 199–205.

https://doi.org/10.1016/j.ijcard.2014.07.002. PMID: 25049018.

51. Elesber A.A., Prasad A., Lennon R.J. et al. Four-year recurrence rate and prognosis of the apical ballooning syndrome. J Am Coll Cardiol. 2007; 50(5): 448–52.

https://doi.org/10.1016/j.jacc.2007.03.050. PMID: 17662398.

52. Sharkey S.W., Pink V.R., Lesser J.R. et al. Clinical profile of patients with high-risk tako-tsubo cardiomyopathy. Am J Cardiol. 2015; 116(5): 765–72.

https://doi.org/10.1016/j.amjcard.2015.05.054. PMID: 26144453.

53. Rudd A.E., Horgan G., Khan H. et al. Cardiovascular and non-cardiovascular prescribing and mortality after takotsubo: Comparison with myocardial infarction and general population. JACC: Adv. 2024; 3(2): 100797.

https://doi.org/10.1016/j.jacadv.2023.100798.